Efficacy of thalidomide in the treatment of myelodysplastic syndromes.
Piccaluga
Pier Paolo
PP
Visani
Giuseppe
G
Finelli
Carlo
C
Grafone
Tiziana
T
Baccarani
Michele
M
Tura
Sante
S
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D013810:Therapeutic Equivalency
D020533:Angiogenesis Inhibitors; D013792:Thalidomide